← Leaderboards
Michael Paul Belmares
Arbor Vita Corporation
$501,760
Attributed
$501,760
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $208.6K · FY2010–13$250K$187.5K$125K$62.5K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$501,760 · 2
By mechanism
R43$501,760 · 2
Top collaborators
No co-investigators on record.
Most similar at Arbor Vita Corporation
Same institution · by research overlap
- Peter S. Lu$3,205,191
- Johannes G Schweizer$3,904,674
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDesignGrantMalignant Neoplasm Of Cervix UteriPreventWomanBaseFollow-UpHuman PapillomavirusLeadMolecularOncogene ProteinsProteinsTumorigenesisCancer EtiologyCancerousAffectCervicalArbor VitaeCellsCessation Of LifeHuman Papilloma Virus VaccineCostAutomation
Grant awards (3)
Development of an HPV-E6 Cervical Neoplasia Test for Use in Centralized Diagnosti$94,891
R43 · FY2013 · CA · contact PI
Development of an HPV-E6 Cervical Neoplasia Test for Use in Centralized Diagnosti$198,247
R43 · FY2012 · CA · contact PI
PDZ-targeted Therapeutics for Cervical Cancer$208,622
R43 · FY2010 · CA · contact PI